CELLCURA Trademark
CELLCURA is a USPTO trademark filed by Cellcura Sciences, Inc.. Status: Pending.
Trademark Facts
| Mark | CELLCURA |
|---|---|
| Serial Number | 99302316 |
| Status | Pending |
| Filing Date | 2025-07-25 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Cellcura Sciences, Inc. |
| Attorney of Record | Cy Bates |
| Prosecution Events | 16 |
| Latest Event | ETOF on 2026-03-19 |
Goods & Services
Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers; Beauty serums; Cosmetic preparations for eyelashes; Eyebrow cosmetics; Non-medicated hair serums; Non-medicated serums for use on eyelashes and eyebrows; Serums for cosmetic purposes; Skin care products, namely, non-medicated skin serum; Facial cream
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-24 | OG Publication Confirmation | PB3 |
| 2026-02-18 | Notice of Publication | PB1 |
| 2026-02-18 | Notification of Notice of Publication | EB4 |
| 2026-02-02 | TRAM Snapshot of App at Pub for Oppostn | PST |
| 2026-01-21 | Amendment and Mail Process Complete | AMC |
| 2026-01-20 | Response to Office Action | ROA |
USPTO Refusals on Record
- identical_marks